“SFJ remained committed to closing our deal, and worked within our company timeline for funding. SFJ demonstrated quick turn-around time during our contracting process, providing flexibility and creativity to meet our needs. The diligence process was timely, with demonstrated clinical expertise.”
— Mark Delong, SVP
Business Development and Strategy, Apellis Pharmaceuticals
SFJ provides the expertise, resources, operational implementation and at-risk funding to accelerate the late-stage clinical development of our Partners’ key pipeline assets.